ivermectin

News

Despite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a treatment for COVID-19.

News

Armed with new pivotal trial results, Eli Lilly is preparing to file for approval of its triple-acting weight-loss therapy, retatrutide, next year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.